Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s726, 2026. DOI: 10.25251/mjfdzc48. Disponível em: https://skin.dermsquared.com/skin/article/view/4022. Acesso em: 2 may. 2026.